Literature DB >> 9066045

Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.

S C Arya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9066045     DOI： 10.1016/s0264-410x(96)00168-5

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  4 in total

1.  Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan.

Authors:  John Wain; Deborah House; Afia Zafar; Stephen Baker; Satheesh Nair; Claire Kidgell; Zulfiqar Bhutta; Gordon Dougan; Rumina Hasan
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.

Authors:  Raphael Simon; Jin Y Wang; Mary A Boyd; Mohan E Tulapurkar; Girish Ramachandran; Sharon M Tennant; Marcela Pasetti; James E Galen; Myron M Levine
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 3.  Vaccines for preventing typhoid fever.

Authors:  Rachael Milligan; Mical Paul; Marty Richardson; Ami Neuberger
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

4.  A safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born mice.

Authors:  Vidya Devi Negi; Arvindhan G Nagarajan; Dipshikha Chakravortty
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.